Does administration of an aminoglycoside in a single daily dose affect its efficacy and toxicity?
about
Dihydrostreptomycin or streptomycin in combination with penicillin G in dairy cattle therapeutics: a review and re-analysis of published data. Part 1: clinical pharmacology.Prospective evaluation of the effect of an aminoglycoside dosing regimen on rates of observed nephrotoxicity and ototoxicityClinical issues surrounding once-daily aminoglycoside dosing in children.In vivo antibacterial effects of simulated human serum profiles of once-daily versus thrice-daily dosing of amikacin in a Serratia marcescens endocarditis experimental model.The use of once-daily dosing of gentamicin in obstetrics and gynecology.Aminoglycoside therapy: current and prospective uses.Application of Bayes theorem to aminoglycoside-associated nephrotoxicity: comparison of extended-interval dosing, individualized pharmacokinetic monitoring, and multiple-daily dosing.Impact of dosage schedule on the efficacy of gentamicin, tobramycin, or amikacin in an experimental model of Serratia marcescens endocarditis: in vitro-in vivo correlationPharmacodynamics of once-daily amikacin in various combinations with cefepime, aztreonam, and ceftazidime against Pseudomonas aeruginosa in an in vitro infection model.Aminoglycoside-induced vestibular injury: maintaining a sense of balance.Once-daily gentamicin dosing in pediatric patients without cystic fibrosis.Once-daily aminoglycoside therapyExperience with a once-daily aminoglycoside program administered to 2,184 adult patients.Pharmacokinetic and pharmacodynamic approach for comparing two therapeutic regimens using amikacin.Adaptive resistance following single doses of gentamicin in a dynamic in vitro model.Once-daily administration of aminoglycosides.Aminoglycoside dosing considerations in intensive care unit patients.Preclinical and clinical evaluation of once-daily aminoglycoside chemotherapy.Once-daily dosing regimen for aminoglycoside plus betalactam combination therapy of serious lower respiratory tract infections.The place of tobramycin in lower respiratory tract infections (LRTI).Optimal aminoglycoside therapy following the sepsis: how much is too much?Single or multiple daily doses of aminoglycosides: a meta-analysis.Therapeutic drug monitoring of tobramycin: once-daily versus twice-daily dosage schedules.Once versus individualized multiple daily dosing of aminoglycosides in critically ill patientsManagement of aminoglycosides in the intensive care unit.
P2860
Q30995411-3940F27D-9CE6-4B8E-819E-4E153C5E0712Q33977062-C3FCF29E-D020-41EE-AC23-1721977CAD92Q35043373-E6CC1E2B-7670-4C9F-BA66-939539326CC8Q35124299-14FF63E0-284E-4D5C-8A78-AB9C34080F9BQ35615501-6625BB44-CF2B-485E-AF91-7C6DE854B220Q35645042-D65BF23A-67B2-4093-B89B-DBC57230B7E9Q35806154-E60D8A58-40D1-4205-A4AA-7F3D54D228BAQ36752610-F56C630F-7083-47E5-A9E0-C710F997289AQ36758305-C545126B-CE10-438A-8491-8CBCB93B30F4Q37224123-2886C7B2-0F46-4354-B89F-D1C0A663F51CQ37697773-930DE84B-8D94-4D17-8087-4830D8F7DA0CQ37730823-52672FCD-2A89-40C0-82C8-FAA693A802F5Q39779327-1DDCF905-0C59-492F-AAC9-36A5DBCF7ED9Q39866827-2880F2E6-C506-4C86-8682-EBA2CEA1CAABQ39881843-52FE2FC6-6886-45B2-9441-E0DAE7F673FFQ40627605-8C25D2D4-30E8-4762-9F78-C619E00D8428Q40794034-B9337193-FD1F-4C1E-86ED-82A85D7DA42BQ40949882-D052105D-E705-4FB9-8781-3A2698EEA55FQ40949888-F40AB784-B140-41DB-B3F5-A4BBBCB12E77Q40949894-61EF0764-213F-4B60-AD65-FA4A0DF31B89Q41963116-8C68AA17-065C-4057-8630-87862A7CAC8AQ42145555-A44E7603-C1D9-4737-95AE-54EA431A0C44Q42537036-8D47B965-85B2-4184-8BE2-C764979E1A36Q42556968-A9DF10BA-05A5-45DF-93B8-3D552BB23ED7Q42908869-6FF6F0D3-410B-450A-B4A0-9638B7354939
P2860
Does administration of an aminoglycoside in a single daily dose affect its efficacy and toxicity?
description
1990 nî lūn-bûn
@nan
1990 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
Does administration of an amin ...... ect its efficacy and toxicity?
@ast
Does administration of an amin ...... ect its efficacy and toxicity?
@en
Does administration of an amin ...... ect its efficacy and toxicity?
@nl
type
label
Does administration of an amin ...... ect its efficacy and toxicity?
@ast
Does administration of an amin ...... ect its efficacy and toxicity?
@en
Does administration of an amin ...... ect its efficacy and toxicity?
@nl
prefLabel
Does administration of an amin ...... ect its efficacy and toxicity?
@ast
Does administration of an amin ...... ect its efficacy and toxicity?
@en
Does administration of an amin ...... ect its efficacy and toxicity?
@nl
P2093
P356
P1476
Does administration of an amin ...... ect its efficacy and toxicity?
@en
P2093
H Ringberg
L Nordström
O Tjernström
S Cronberg
P304
P356
10.1093/JAC/25.1.159
P407
P577
1990-01-01T00:00:00Z